From: Angiogenesis in cancer of unknown primary: clinicopathological study of CD34, VEGF and TSP-1
Characteristic | No | (%) |
---|---|---|
Patients | 81 | Â |
Sex | Â | Â |
   Male | 39 | 48 |
   Female | 42 | 52 |
Age (Years) | Â | Â |
   Median | 66 |  |
   Range | 37–84 |  |
PS | Â | Â |
   Median | 1 |  |
   Range | 0–3 |  |
Histology | Â | Â |
   Adenocarcinoma | 62 | 77 |
Well- and moderately differentiated | 27 | 43 |
Poorly differentiated | 35 | 57 |
   Undifferentiated carcinoma | 15 | 18 |
With neuroendocrine features | 5 | 33 |
Other undifferentiated neoplasms | 11 | 67 |
   Squamous cell carcinoma | 4 | 5 |
Metastatic sites at presentation | Â | Â |
   Liver and/or multiple visceral involvement | 17 | 21 |
   Lymph nodes | 23 | 29 |
Mediastinal-retroperitoneal | 17 | 74 |
Axillary | 2 | 9 |
Cervical | 4 | 17 |
   Peritoneal cavity | 19 | 23 |
Peritoneal adenocarcinomatosis in females | 14 | 74 |
Malignant ascites and other site | 5 | 26 |
   Lung | 5 | 6 |
   Bones | 5 | 6 |
   Brain | 4 | 5 |
   Neuroendocrine tumors | 4 | 5 |
   Multiple | 4 | 5 |